Login

Sean Hall, CEO, Medlab Clinical Ltd 00:00:00

Share On Facebook Share On Twitter

Medlab Clinical accelerating VMS business in Australia, and NanaBis globally

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Gary Economou Discusses Focus Graphite’s High-Grade Deposit and Growing Market Demand
00:10:00
Improving health and well-being in our community|Robert G. Riney,President and CEO,Henry Ford Hospital
00:10:00
Market Fundamentals and Opportunities: Insights from Jeff Krumpelman | Jeff Krumpelman - Chief Investment Strategist, Mariner Wealth Advisors
00:10:00
How Mister Spex Transformed Europe's Optical Market: A Decade of Innovation and Growth | Dirk Graber , CEO, Mister Spex SE.
00:10:00
Blackstone we deliver for investors by building businesses that power tomorrow’s economy|Stephen A. Schwarzman,Chairman,The Blackstone Group
00:10:00
Avenir Telecom switches to a B2B model. | Robert Schiano Lamoriello, CEO, Avenir Telecom SAAVT:PAR
00:10:00
Will Kingston on Debating Ideas and the Search for Truth|William Kingston, Professor, Trinity Business School
00:10:00
Selci (Biesse): 'We Need Young Engineers to Keep Up with Technology | Roberto Selci - CEO of Biesse
00:10:00
Ken Fisher Critiques the Efficacy of Stop-Loss Strategies | Ken Fisher, founder , Fisher Investments.
00:10:00
Clearing the Path for Healing and Reform in Policing America
00:10:00
VD Clein Ullenvik and CFO Irene Wisenborn Belander Present the Company | Clein Johansson Ullenvik - President and CEO of Alligo AB
00:10:00
CEO Andrew Hider Reflects: ATS Corporation's Transformative Year Post-IPO | Andrew Hider - CEO of ATS Corp

© 2017 - Neuhu+